Fetal gene reactivation

Current Opinion in Genetics and Development

Volumn 8, Issue 3, 1998, Pages 366-370

  Swank, Richard A ^a   Stamatoyannopoulos, George ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HEMOGLOBIN F;

DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO DEVELOPMENT; FETUS; FETUS DEVELOPMENT; GENE ACTIVATION; GENE MUTATION; HEMOGLOBINOPATHY; HUMAN; PRIORITY JOURNAL; REVIEW; SILENT GENE;

EID: 0032102618     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80095-6     Document Type: Article

References (53)

1. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. Stamatoyannopoulos G, Nienhuis AW, Majerus P, Varmus H. The Molecular Basic of Blood Diseases. 1994;107-156 WB Saunders, Philadelphia.
2. Liebhaber Sa, Wang Z, Cash FE, Monks B, Russell JE. Developmental silencing of the embryonic ζ-globin gene: concerted action of the promoter and the 3′-flanking region combined with stage-specific silencing by the transcribed segment. Mol Cell Biol. 16:1996;2637-2646.
3. TomHon C, Zhu W, Millinoff D, Hayasaka K, Slighton JL, Goodman M, Gumucio DL. Evolution of a fetal expression pattern via cis changes near the γ globin gene. J Biol Chem. 272:1997;14062-14066.
4. Grosveld F, Blom van Assendelft G, Greaves DR, Kollias G. Position-independent, high level expression of the human β-globin gene in transgenic mice. Cell. 51:1987;975-985.
5. Forrester WC, Epner E, Driscoll MC, Enver T, Brice M, Papayannopoulou Th, Groudine M. A deletion of the human β-globin locus activation region causes a major alteration in chromatin structure and replication across the entire β-globin locus. Genes Dev. 4:1990;1637-1649.
6. Kioussis D, Festenstein R. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr Opin Genet Dev. 7:1997;614-619.
7. Wijgerde M, Grosveld F, Fraser P. Transcription complex stability and chromatin dynamics in vivo. Nature. 377:1995;209-213.
8. Milot E, Strouboulis J, Trimborn T, Wifgerde M, de Boer E, Langeveld A, Tan-Un K, Vergeer W, Yannoutsos N, Grosveld F, Fraser P. Heterochromatin effects on the frequency and duration of LCR mediated gene transcription. Cell. 87:1996;105-114.
9. of special interest Antoniou M, Grosveld F. β-globin dominant control region interacts differently with distal and proximal promoter elements. Genes Dev. 4:1990;1007-1013.
10. II130.
11. Li Q, Stamatoyannopoulos JA. Position independence and proper developmental control of γ-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol Cell Biol. 14:1994;6087-6096.
12. Aγ gene contained 600bp of 3′ sequences, indicating that the mechanism whereby the LCR achieves position-independent expression involves interaction with gene proximal regulatory elements distinct from the promoter.
13. Raich N, Clegg CH, Grofti J, Romeo PH, Stamatoyannopoulos G. GATA1 and YY1 are developmental repressors of the human ε-globin gene. EMBO J. 14:1995;801-809.
14. Li Q, Clegg C, Peterson K, Shaw S, Raich N, Stamatoyannopoulos G. Binary transgenic mouse model for studying the trans control of globin gene switching. Proc Natl Acad Sci USA. 94:1997;2444-2448.
15. Enver T, Raich N, Ebens AJ, Papayannopoulou Th, Costantini F, Stamatoyannopoulos G. Developmental regulation of human fetal to adult globin gene switching in transgenic mice. Nature. 344:1990;309-313.
16. Behringer RR, Ryan TM, Palmiter RD, Brinster RL, Townes TM. Human γ- to β-globin gene switching in transgenic mice. Genes Dev. 4:1990;380-389.
17. Peterson KR, Stamatoyannopoulos G. Role of gene order in developmental control of human γ and β-globin gene expression. Mol Cell Biol. 13:1993;4836-4843.
18. Dillon N, Trimborn T, Strouboulis J, Fraser P, Grosveld F. The effects of distance on long-range chromatin interactions. Mol Cell. 1:1997;131-139.
19. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol. 13:1993;2776-2786.
20. Donze D, Townes TM, Bieker JJ. Role of erythroid kruppel like factor in human γ to β-globin gene switching. J Biol Chem. 270:1995;1955-1959.
21. Asano H, Stamatoyannopoulos G. Activation of β-globin promoter by Erythroid Kruppel Like Factor. of special interest Mol Cell Biol. 18:1998;102-109 EKLF binds to the β gene CACCC box and is essential for β gene expression. EKLF does not activate the γ gene, the CACCC sequence of which differs from that of the β gene. CACCC box swapping between the γ and β genes indicated that the specificity of β promoter activation by EKLF is determined by the overall structure of the β promoter rather than solely through the sequence of the β gene CACCC box.
22. Wijgerde M, Gribnau J, Trimborn T, Nuez B, Philipsen S, Grosveld F, Fraser P. The role of EKLF in human β-globin gene competition. Genes Dev10:1996;2894-2902.
23. Perkins AC, Gaensler KML, Orkin SH. Silencing of human fetal globin expression is impaired in the absence of the adult β-globin gene activator protein EKLF. Proc Natl Acad Sci USA. 93:1996;12267-12271.
24. Papayannopoulou Th, Brice M, Stamatoyannopoulos G. Hemoglobin F synthesis in vitro: evidence for control at the level of primitive erythroid stem cells. Proc Natl Acad Sci USA. 74:1977;2923-2927.
25. Al-Khatti A, Veith RW, Papayannopoulou Th, Fritsch EF, Goldwasser E, Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Eng J Med. 317:1987;415-420.
26. Umemura T, Al-Khatti A, Papayannopoulou Th, Stamatoyannopoulos G. Fetal hemoglobin synthesis in vivo: direct evidence for control at the level of erythroid progenitors. Proc Natl Acad Sci USA. 85:1988;9278-9282.
27. Benz EJ, Steggles AW, Geist CE, Nienhuis AW. Hemoglobin switching in sheep. J Biol Chem. 253:1978;5025-5032.
28. Torrealba de Ron AT, Papayannopoulou Th, Knapp MS, Fu MF, Knitter G, Stamatoyannopoulos G. Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of Hb F by 5 Azacytidine. Blood. 63:1984;201-210.
29. Papayannopoulou Th, Torrealba de Ron AT, Veith R, Knitter G, Stamatoyannopoulos G. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science. 224:1984;617-619.
30. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. New Engl J Med. 332:1995;1317-1322.
31. DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci USA. 79:1982;4428-4431.
32. + thalassemia. New Engl J Med. 307:1982;1469-1475.
33. Lowrey CH, Nienhuis AW. Brief report: Treatment with azacitidine of patients with end-stage β-thalassemia. New Eng J Med. 329:1993;845-848.
34. Perrine SP, Greene MF, Faller DV. Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med. 312:1985;334.
35. Perrine SP, Rudolph A, Faller DV, Roman C, Cohen RA, Chen SJ, Kan YW. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci USA. 85:1988;8540-8542.
36. Constantoulakis P, Papayannopoulou Th, Stamatoyannopoulos G. α-Amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood. 72:1988;1961-1967.
37. Perrine SP, Ginder GD, Faller DV, Dover G, Ikuta T, Witkowska EH, Cai SP, Vichinsky EP, Olivieri NF. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. New Engl J Med. 328:1993;81-86.
38. Sher GD, Ginder GD, Little J, Yang S, Dover G, Olivieri NF. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. New Engl J Med. 332:1995;1606-1610.
39. Stamatoyannopoulos G, Blau CA, Nakamota B, Josephson B, Li Q, Liakopoulou E, Pace B, Papayannopoulou Th, Brusilow S, Dover G. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood. 84:1994;3198-3204.
40. Liakopoulou E, Blau CA, Li A, Josephson B, Wolf JA, Raisys V, Dover G, Papayannopoulou Th, Stamatoyannopoulos G. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood. 86:1995;3227-3235.
41. Little JA, Dempsey NJ, Tuchman M, Ginder GD. Metabolic persistence of fetal hemoglobin. Blood. 85:1995;1712-1718.
42. Peters A, Rohloff D, Kohlmann T, Renner F, Jantschek G, Kerner W, Fehm HL. Fetal hemoglobin in starvation ketosis of young women. Blood. 91:1998;691-694.
43. Torkelson S, White B, Faller DV, Phipps K, Pantazis C, Perrine SP. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. of special interest Blood Cell Mol Dis. 22:1996;150-158 A factor that limits the therapeutic efficiency of short-chain fatty acids is their rapid oxidative metabolism. This paper shows that derivatives of phenoxyacetic and phenylalkyl acids - which possess resistance to oxidative metabolism and have long half lifes in vivo - induce fetal hemoglobin in BFUe cultures. Some of these compounds also stimulate BFUe growth in contrast to butyrate, which has antiproliferative effects and inhibits cell growth.
44. Glauber JG, Wandersee NJ, Little JA, Ginder GD. 5′-Flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol. 11:1991;4690-4697.
45. Aγ gene promoter mutants. Blood. 88:1996;1079-1083.
46. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121.
47. Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, Roth SY, Allis CD. Transcription-linked acetylation by gcn5p of histones H3 and H4 at specific lysines. Nature. 383:1996;269-272.
48. II250 subunit of TFIID has histone acetyltransferase activity. Cell. 87:1996;1261-1270.
49. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959 One of the first of numerous papers published since the description of endogenous histone acetyltransferase activity in transcriptional adaptor, co-activator, or components of the transcriptional machinery. Importantly, the authors show that p300/CBP acetylates all of the core histones in nucleosomes. Thus, p300/CBP may regulate gene activity directly via its targeted acetylation.
50. Vettese-Dadey M, Grant PA, Hebbes TR, Crane-Robinson C, Allis CD, Workman JL. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. of special interest EMBO J. 15:1996;2508-2518 This paper uses antibodies to acetylated H4 and acetylated H3 to show that nucleosome cores with the highest affinity for transcription factors contain histones highly acetylated on histone H4. Highly acetylated H3 was shown to play much less of a role in binding. This finding illustrates the specific effects histone acetylation can have upon gene regulation and may be a harbinger of future work examining the role of specific acetyl-isoforms of the core histones and their effects on transcriptional factor binding.
51. Pazin MJ, Kadonaga JT. Whats up and down with histone deacetylation and transcription? of special interest Cell. 89:1997;325-328.
52. McCaffrey PG, Newsome DA, Fibach E, Yoshida M, Su MSS. Induction of γ-globin by histone deacetylase inhibitors. Blood. 90:1997;2075-2083.
53. Ginder GD, Whitters MJ, Pohlman JK. Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate. Proc Natl Acad Sci USA. 81:1984;3954-3958.